These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34647538)

  • 1. [Chronic use of the unfixed combination of ACE-inhibitors and beta-blockers in Italy from 2013 to 2019 through the healthcare administrative data.].
    Calabria S; Piccinni C; Ronconi G; Dondi L; Cinconze E; Esposito I; Addesi A; Pedrini A; Maggioni AP; Martini N
    Recenti Prog Med; 2021 Oct; 112(10):678-686. PubMed ID: 34647538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the COVID-19 pandemic on the management of chronic heart failure.
    McGinlay M; Straw S; Jagger J; Nouri B; Gierula J; Witte KK
    Rev Cardiovasc Med; 2021 Jun; 22(2):271-276. PubMed ID: 34258895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
    Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
    Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming.
    Nassiri M; Babina M; Dölle S; Edenharter G; Ruëff F; Worm M
    J Allergy Clin Immunol; 2015 Feb; 135(2):491-9. PubMed ID: 25441633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta adrenergic blockers lower renin in patients treated with ACE inhibitors and diuretics.
    Holmer SR; Hense HW; Danser AH; Mayer B; Riegger GA; Schunkert H
    Heart; 1998 Jul; 80(1):45-8. PubMed ID: 9764058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy.
    Pathak JV; Dass EE
    Indian J Pharmacol; 2015; 47(2):148-52. PubMed ID: 25878372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
    Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
    Bramlage P; Schmieder RE; Gitt AK; Baumgart P; Mahfoud F; Buhck H; Ouarrak T; Ehmen M; Potthoff SA;
    Trials; 2015 Dec; 16():581. PubMed ID: 26686682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE inhibitor ramipril is more effective than the beta-blocker atenolol in reducing left ventricular mass in hypertension. Results of the RACE (ramipril cardioprotective evaluation) study on behalf of the RACE study group.
    Agabiti-Rosei E; Ambrosioni E; Dal Palù C; Muiesan ML; Zanchetti A
    J Hypertens; 1995 Nov; 13(11):1325-34. PubMed ID: 8984131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
    Willenheimer R; van Veldhuisen DJ; Silke B; Erdmann E; Follath F; Krum H; Ponikowski P; Skene A; van de Ven L; Verkenne P; Lechat P;
    Circulation; 2005 Oct; 112(16):2426-35. PubMed ID: 16143696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimising the use of beta-blockers in older patients with heart failure.
    Owen A
    Drugs Aging; 2002; 19(9):671-84. PubMed ID: 12381236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study.
    Ouwerkerk W; Voors AA; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Hillege HL; Lang CC; Ter Maaten JM; Ng LL; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zannad F; Metra M; Zwinderman AH
    Eur Heart J; 2017 Jun; 38(24):1883-1890. PubMed ID: 28329163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effects of β-blockers on renin-angiotensin system inhibitors for patients after acute myocardial infarction treated with primary coronary revascularization.
    Konishi M; Haraguchi G; Yoshikawa S; Kimura S; Inagaki H; Isobe M
    Circ J; 2011; 75(8):1982-91. PubMed ID: 21697605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
    Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
    Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisoprolol in chronic heart failure.
    Davis M
    Hosp Med; 2000 Feb; 61(2):120-3. PubMed ID: 10748791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of the efficacy of bisoprolol administration by cardiopulmonary exercise testing in patients with heart failure].
    Terzi S; Dayi SU; Akbulut T; Dağ O; Köse H; Satiroğlu O; Sayar N; Bilsel T; Aksoy S; Yeşilçimen K
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):313-8. PubMed ID: 14675880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
    Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T
    Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.